Narcolepsy: Overview for Payer Audience

This presentation delves into the landscape of Narcolepsy Type 1, covering prevalence, pathophysiology, and economic burden. It evaluates the competitive environment, highlighting current therapies and challenges like efficacy gaps and compliance issues. Unmet clinical needs such as residual symptoms and economic impacts are addressed, alongside an innovative target product profile emphasizing dual modulation, improved efficacy, and economic advantages. The value proposal focuses on enhanced...